Finural

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Finural

Property Description
Active ingredient Finasteride (INN)
Form Oral tablet (Systemic delivery)
Pharmacological class 5-Alpha-Reductase Inhibitor
General purpose To modulate hormone-driven biological processes
Origin Synthetic 4-azasteroid compound

What Type of Medicine is Finural? (Identity and Classification)

Finural is a prescription-only medication containing the active compound Finasteride, which is classified as a 5-Alpha-Reductase Inhibitor. This agent is a synthetic 4-azasteroid designed for systemic delivery, meaning it acts throughout the body. Finural is typically supplied as an oral tablet, distinguishing it as a systemic preparation, unlike topical formulations. As one of several trade names for Finasteride, it reflects a globally recognized agent in its pharmacological class, known alongside well-established products like Proscar and Propecia.

Composition and Mechanism of Action (Core Function)

As a single-ingredient product, Finural is composed of Finasteride combined with necessary inactive excipients that form the oral dosage unit. Its primary pharmacological function is rooted in its ability to act as a competitive and specific inhibitor of the Type II 5alpha-reductase enzyme. This enzyme is essential for converting the androgen Testosterone into the more potent androgen, Dihydrotestosterone (DHT). The targeted inhibition of this pathway is clinically recognized for achieving a substantial reduction of DHT concentrations in both the serum and target tissues.

General Therapeutic Purpose (High-Level Benefit)

The consequence of this specific reduction in Dihydrotestosterone (DHT) levels is the general mitigation of biological processes driven by this hormone in androgen-sensitive tissues, such as the prostate gland and hair follicles. This makes Finural a valuable tool for modulating certain tissue changes in men, providing a pharmacologically distinct intervention where high DHT activity is a primary factor.

Regulatory References

  1. Finasteride (MedlinePlus)

What side effects are possible with Finural?

Finural's safety profile is documented by regulatory authorities, with potential adverse reactions generally classified by frequency and affected body system. As a 5-Alpha-Reductase Inhibitor, many documented effects relate to the modulation of hormone levels.

Adverse reactions are officially grouped into System-Organ Classes including Reproductive System and Breast Disorders, Psychiatric Disorders, Skin and Subcutaneous Tissue Disorders, and Immune System Disorders.

Frequency-Classified Adverse Reactions

The following are examples of adverse reactions listed in official documents:

Classification Examples of Documented Adverse Reactions
Common Decreased libido, erectile dysfunction, ejaculation disorder.
Uncommon Breast tenderness and enlargement (gynaecomastia), rash.
Not Known Persistent sexual dysfunction after discontinuation, testicular pain, depression, suicidal ideation, and severe hypersensitivity reactions.

Key Safety Characteristics

Official regulatory documents note that sexual adverse reactions are often reported as most frequent early in therapy and, for the majority of patients, may resolve with continued treatment. However, the official documentation also includes post-marketing reports of the persistence of sexual dysfunction after the medicine has been discontinued.

Specific serious adverse reactions that have been officially noted include reports of male breast cancer and an observed increased risk of high-grade prostate cancer in trials involving the higher dose.

Population-Specific Constraints

Finural is contraindicated in women who are or may potentially be pregnant due to the risk of fetal harm. Consequently, safety regulations specify that pregnant women should not handle crushed or broken tablets. The medicine is not indicated for use in pediatric patients and carries an official caution for use in patients with hepatic impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Finural contains the active compound Finasteride. The official regulatory information regarding human overdosage indicates a generally low acute toxicity profile within tested clinical settings.

Documented Overdose Profile

In clinical studies, Finasteride was tested at single doses up to 400 mg and multiple doses up to 80 mg per day for three months. These levels of exposure were not associated with adverse effects or specific clinical manifestations of overdose. Consequently, no specific symptoms or laboratory abnormalities are formally documented in the official regulatory labeling as typical manifestations of Finasteride overdosage in humans.

Emergency Actions and Treatment

Due to the lack of documented adverse clinical outcomes from high-dose human exposure, regulatory authorities state that no specific treatment can be recommended for an overdose of Finural. There is no known specific antidote. Management of an overdose is considered symptomatic and supportive, based on the patient’s clinical presentation.

When to Seek Immediate Medical Attention

Despite the drug’s non-specific acute overdose profile, any suspected overdose requires immediate action. Urgent medical attention must be sought if the individual exhibits signs of a severe medical emergency, such as difficulty breathing, seizures, collapse, or inability to be awakened. Contact emergency services or a poison control center immediately in these critical situations.

Therapeutic Uses of Finural

What Finural Treats: Main Uses and Benefits

The primary role of Finural is to offer symptomatic relief and provide supportive therapeutic benefit in various clinical contexts. It is generally used to help manage the intensity of symptoms that are noticeable or temporarily interfere with functional stability. Its role is focused on symptomatic relief. This aligns with the therapeutic principles applied to medications used to manage acute, disruptive manifestations.


Key Symptom Domains and Benefits

Finural is commonly applied in situations involving symptoms related to physical discomfort associated with acute or episodic changes. It is relevant in clinical settings that involve acute or unstable symptom patterns and periods of increased physiological stress. The medication helps address symptom clusters that may become intense or disruptive, leading to temporary functional strain. It is applicable across conditions characterized by episodic or fluctuating manifestations where short-term symptomatic assistance is needed. This usage provides support that helps ease the overall symptom load and assists with maintaining functional stability.


Quick Facts

Therapeutic Focus
Applied in contexts marked by increased discomfort or tension
Used when symptoms interfere with daily functioning
Helps address symptom clusters that may become intense

Regulatory References

  1. Drug Office of the Department of Health, Hong Kong guidance

Eligibility and Restrictions for Use

Who Can and Cannot Use Finural? (Eligibility Profile)

Finural is officially indicated only for use in adult men, defined as those 18 years and older. The medicine's regulatory profile establishes strict limitations and exclusions, classifying populations based on gender, age, and physiological status.

Absolute Contraindications (Must Not Use)

The medicine is strictly contraindicated and must not be used by women in any capacity, particularly those who are pregnant or may potentially become pregnant, due to the established risk of causing abnormalities in a male fetus. Finural is also contraindicated in patients with a known hypersensitivity to Finasteride or any excipient, including those with rare hereditary issues like total lactase deficiency.

Population Restrictions

Finural is not indicated for the pediatric population (under 18 years of age) as safety and efficacy have not been established in this group. Use requires caution in adult men with liver function abnormalities (hepatic impairment). Conversely, official labeling states that no dosage adjustment is necessary for older adults or men with renal impairment. Pregnant women must not handle crushed or broken tablets.

What should I know about interactions with other medicines?

Finural (finasteride) is a medication that belongs to a class of drugs called 5-alpha-reductase inhibitors. Its interaction profile with other medicines and products is generally considered limited, meaning it is not known to significantly affect or be affected by many commonly prescribed medications. However, it is essential to inform your healthcare provider of all prescription drugs, over-the-counter medicines, vitamins, and herbal supplements you are currently taking.

Drug-Drug Interactions

Clinical studies have indicated that Finural does not appear to interact with drugs such as propranolol, digoxin, glibenclamide, warfarin, theophylline, or antipyrine. No clinically significant negative interactions have been observed when Finural is taken concomitantly with these agents.

Category Examples Potential Effect
Alpha-Blockers Doxazosin Often used together to treat Benign Prostatic Hyperplasia (BPH) with no significant interaction concerns.
Cytochrome P450 System N/A Finasteride is metabolized primarily via the CYP450 3A4 system; however, it does not significantly impact the metabolism of other drugs that use this system.

Other Interactions

  • Food and Alcohol: Finural can be taken with or without food. There are no known significant interactions with alcohol or specific foods.
  • PSA Testing: Finural is known to decrease serum Prostate-Specific Antigen (PSA) levels, which are used to screen for prostate cancer. You must inform your doctor that you are taking Finural, as this reduction must be accounted for when interpreting PSA test results. This is an essential consideration, not a drug-drug interaction.

Mechanism of Action

Selective Inhibition of 5alpha-Reductase

Finural's mechanism centers on acting as a specific inhibitor of the Type II 5alpha-reductase isoenzyme . This enzyme is responsible for converting Testosterone into the more biologically active androgen, Dihydrotestosterone (DHT). By binding to the enzyme's active site, the drug inhibits this metabolic step, initiating the physiological change by controlling the primary hormonal input.


⬇️ Reducing Dihydrotestosterone (DHT) Levels

The resulting molecular cascade is a reduction in both systemic and tissue-level concentrations of DHT. The resulting reduction in DHT diminishes the hormonal signal driving cell proliferation in certain androgen-sensitive tissues. This change in the hormonal environment leads to the anti-proliferative modulation of the target tissue, which is the core physiological effect of the drug.


⏳ Time-Dependent Tissue Modulation

While the enzyme inhibition occurs rapidly, the resulting physiological effect on tissue size and structure is inherently time-dependent. The final tissue response is constrained by the slower biological process of cellular atrophy. The final tissue response follows the sustained reduction of the DHT stimulus over a period of months. This mechanism also presents a known limitation: the drug has only minor activity against the Type I 5alpha-reductase isoenzyme, meaning residual DHT synthesis persists.

Dosage and Administration Information

How Finural is Used: Official Administration Guidelines

Finural (Finasteride) is a medication with official usage protocols. The drug is administered exclusively via the oral route as a film-coated tablet, available in two primary dosage strengths: 1 mg and 5 mg.


Standard Dosing and Frequency

Finural must be taken once daily at a fixed time, regardless of meals, as the labels permit administration with or without food. The precise strength depends on the context of use: 5 mg once daily is the standard regimen for Benign Prostatic Hyperplasia (BPH), while 1 mg once daily is used for male pattern hair loss. The tablet must be swallowed whole and should not be crushed, broken, or split.


Duration and Special Use Considerations

Treatment with Finural is generally long-term. For conditions like BPH, official guidance suggests that a minimum of six months of daily use may be required before the benefit can be adequately assessed. Similarly, the assessment of hair loss improvement requires continuous use for at least three months.

No dosage adjustment is required for older adults or in patients with renal impairment, even in cases of significant kidney function reduction. Conversely, the medication is not indicated for use in children or adolescents. If a daily dose is missed, instructions advise resuming the standard schedule the following day, emphasizing that the patient should not take a double dose to compensate.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Finural

The information presented here summarizes the type of official research—such as large clinical trials and scientific reviews—that was studied for Finural (Finasteride). This section focuses only on what the studies explored and what the findings suggest, according to regulatory and peer-reviewed sources, without providing clinical advice or making claims about individual outcomes.


Evidence for use in Benign Prostatic Hyperplasia (BPH)

The research base for Finural in the context of BPH is primarily composed of large-scale Randomized Controlled Trials (RCTs). The research was used in research exploring how symptoms change over time by comparing Finural against an inactive pill (placebo) or sometimes against other active agents. Researchers monitored objective and subjective endpoints, including outcomes related to physical discomfort (urological symptom scores), the ability to pass urine (flow rate), and prostate volume using imaging.

Studies observed patterns over defined time intervals, with follow-up durations sometimes extending up to four years or more. Data show patterns related to standardized symptom scores in the Finural group, relative to the patterns observed in the placebo group. What remains uncertain is the exact magnitude of change in every patient; research suggests that observations related to symptom scores may be more pronounced in patients documented with a larger prostate at the start of the study.

Evidence for use in Androgenetic Alopecia (Male-Pattern Hair Loss)

For male-pattern hair loss, the evidence landscape also features multiple Randomized, double-blind, placebo-controlled clinical studies. Research examined this use in men, typically aged 18 to 41, with hair thinning on the top and middle of the scalp. The studies monitored specific objective measurements of hair density (hair count), alongside subjective assessments of hair appearance using standardized photographic evaluation.

Long-term follow-up studies described the sustained measurement patterns, and data show patterns indicating that the continuation of observation is relevant to sustained measurements. A key point documented in the research is that when use was discontinued, measured patterns were observed to return toward baseline. Results apply only to the populations studied; there is limited information for long-term outcomes in men significantly older than 41 years of age.

Evidence in Special Populations and Clinical Contexts

Research has specifically explored Finural in the context of prostate cancer chemoprevention (prevention) in men ge 55 years of age. One major, long-term RCT known as the Prostate Cancer Prevention Trial (PCPT) was conducted over seven years to evaluate the overall incidence of prostate cancer.

The findings were mixed: the original trial reported a lower overall measurement of cancer incidence in the Finasteride group compared to the placebo group. However, among those individuals who were diagnosed with cancer during the trial, the researchers reported a higher relative proportion of high-grade tumors (Gleason score 8–10). This specific finding complicated the research interpretation, and due to the complexity, official regulatory bodies have not permitted this use.

Key Studies & References

  1. Finasteride Drug Information: MedlinePlus Drug Monograph (NIH)

Frequently Asked Questions (FAQ)

Common questions about Finural (FAQ)

Q: Is Finural the same kind of drug as [Competitor Drug Name]?

Finural contains Finasteride, which is officially classified as a 5-Alpha-Reductase Inhibitor. This means it belongs to the same pharmacological class as other drugs that share this core function. However, drugs within the same class may contain different active ingredients, chemical structures, and specific properties, which can influence their clinical profile.

Q: How long is Finural typically prescribed for?

According to official product information, treatment with Finural is generally intended for long-term and continuous use. While a minimum duration of three to six months is needed to assess the initial benefit, continuous daily use is typical for sustained results in its indicated conditions.

Q: Can Finural affect mood or sleep?

Regulatory documents indicate that adverse reactions are classified under Psychiatric Disorders, including reports of depression and suicidal ideation. Additionally, sleep disturbances, such as insomnia, and feelings of fatigue have been documented in post-marketing reports.

Q: Can Finural be taken alongside vitamins?

Regulatory health information describes the importance of informing a healthcare professional about all the medicines, non-prescription drugs, and herbal supplements being taken, including vitamins. This allows the doctor to review the full combination.

Q: Can people with liver problems use Finural?

Finural is extensively metabolized in the liver. Official labeling advises that its administration requires caution in patients who have liver function abnormalities or hepatic impairment, as the drug is extensively metabolized in the liver.

Q: What is the maximum amount of time Finural can be used continuously?

Official guidance does not specify a maximum duration or limit for the continuous use of Finural. Clinical studies have followed patients for years, and benefits for both indicated conditions are sustained only through continuous, long-term use.

Q: Does Finural cause weight gain?

Changes in body weight are not listed among the most common adverse reactions to Finural. However, reports of unusual weight gain or loss have been included in official side effect lists as less common events reported during post-marketing surveillance.

Q: Can Finural cause hair loss?

Finural is indicated specifically for the treatment of male pattern hair loss (androgenetic alopecia). Therefore, it is intended to modulate the hormonal signal that causes hair thinning, and it is not documented as a cause of general hair loss in official adverse reaction documents.

Q: Are there any serious side effects I should know about for Finural?

Official warnings document serious adverse reactions and findings reported during clinical use. These include reports of persistent sexual dysfunction, depression, and suicidal ideation. Observations from research trials have also noted an increased relative risk of high-grade prostate cancer with the higher dose and reports of male breast cancer.

Q: Does Finural interact with common painkillers like ibuprofen?

Studies have not identified clinically significant drug interactions between Finural and many commonly prescribed agents. According to regulatory-backed information, no known clinically significant interactions have been established between Finural and nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen.

Q: Can I drink alcohol while taking Finural?

The official documentation states there are no known significant interactions between Finural and alcohol. The drug is generally described as being able to be used by people who consume alcohol.

Q: Are there any herbal supplements that interact with Finural?

While Finural has a limited interaction profile, regulatory-backed consumer information advises that certain herbal remedies, such as St. John’s Wort, have been suggested to theoretically affect how Finasteride works, highlighting the need to inform a healthcare provider of all supplements being used.

Q: Is it safe to take Finural with blood pressure medication?

Finural has been studied and shown to have no clinically significant negative interactions with several cardiovascular drugs, including specific alpha-blockers like Doxazosin. Official product information emphasizes the need for a healthcare professional to review a patient's entire combination of medications.

Q: Should Finural be taken in the morning or at night?

The official guidance emphasizes that the medication must be taken once daily at a fixed time to maintain consistent drug levels. There is no official clinical recommendation that states the drug must be taken in the morning versus the evening.

Q: Is it normal to feel [vague side effect, e.g., slightly dizzy] when starting Finural?

Dizziness is one of the adverse reactions that has been reported during clinical experience. Official documents note that the frequency of certain side effects, particularly sexual ones, is often highest early in therapy, but many of these may resolve with continued treatment.

Q: Why do some people say Finural changed their energy levels?

The official documentation does not provide a specific physiological explanation for changes in energy, though fatigue is one of the symptoms that has been reported to regulatory Adverse Event Reporting Systems.

Q: Does Finural show up on drug tests?

Finasteride is a substance that can be detected in specialized laboratory testing. Official product information indicates that the patient should notify testing personnel, particularly due to the drug’s historical classification as a prohibited masking agent by some sports governing bodies.

Q: How does Finural affect laboratory tests?

Finural is specifically known to affect the results of the Prostate-Specific Antigen (PSA) test. Regulatory information confirms the drug reduces serum PSA concentration by approximately 50%, a factor that must be taken into account by a physician when interpreting the test for prostate cancer screening.

Q: What are the ingredients besides the active one in Finural tablets?

Finural tablets are composed of the active ingredient Finasteride, combined with necessary inactive excipients that form the oral dosage unit. These inactive ingredients typically include binders and fillers such as lactose monohydrate, microcrystalline cellulose, starch, and magnesium stearate, along with film-coating components.

Q: Does Finural have any warnings about driving or operating machinery?

Official documents do not contain a specific caution or warning prohibiting driving or operating machinery. However, reported side effects such as dizziness or lightheadedness are listed in official product information.

Q: What if I take too much Finural?

If more than the prescribed amount is taken, regulatory guidance instructs patients to contact a healthcare practitioner, hospital emergency department, or Poison Control Centre immediately. Although clinical trials have studied doses higher than the standard, immediate medical advice is always necessary in case of an overdose.

Q: Does Finural affect fertility?

Reports of male infertility and/or poor quality of semen, including reduced sperm count and volume, have been documented in post-marketing adverse reaction reports. These changes in semen quality are often reported to be reversible upon the discontinuation of the medication.

Q: Why is Finural classified as [Drug Classification, e.g., a selective inhibitor]?

Finural is classified as a 5alpha-reductase inhibitor because its core mechanism is to act as a specific inhibitor of the Type II 5alpha-reductase isoenzyme. This inhibition prevents the enzyme from performing its function of converting Testosterone into the more potent androgen, Dihydrotestosterone (DHT). The classification directly reflects the specific molecular target and action of the drug.

How should Finural be stored and disposed of?

Storage and Handling Requirements

Finural tablets must be stored at Controlled Room Temperature, which is defined as 20 to 25 C (68 to 77 F), with excursions permitted up to 30 C.

Storage Constraint Requirement
Temperature Controlled Room Temperature
Protection Protect from light; keep container tightly closed
Safety Keep out of the sight and reach of children
Special Handling Pregnant women must not handle crushed or broken tablets

The product must be kept in its original, tightly closed container and protected from light and moisture. A crucial handling requirement is that women who are pregnant or may become pregnant must not handle crushed or broken Finural tablets due to the risk of absorption.

Disposal Instructions

Unused or expired Finural should be disposed of by following local pharmaceutical regulations. The preferred method is using an authorized drug take-back program. If a take-back option is unavailable, the medicine must be rendered undesirable by mixing it with materials like dirt or used coffee grounds, placed in a sealed container, and discarded in the household trash. The product must not be disposed of via wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Finural found in:

A-Z Index: